Adhikari Srijana, Shrestha Ujjowala D
Department of Pediatric Ophthalmology and Strabismus, Tilganga Institute of Ophthalmology, Kathmandu, Nepal.
Clin Ophthalmol. 2017 Dec 20;12:7-11. doi: 10.2147/OPTH.S149806. eCollection 2018.
To assess the outcome of cataract surgery with hydrophilic acrylic intraocular lens (IOL) implantation in children with congenital and developmental cataracts.
A retrospective review of medical records of children with congenital or developmental cataracts who underwent cataract surgery with hydrophilic IOL implantation, from January 2011 to December 2014 in a tertiary eye hospital in Nepal. Primary posterior capsulotomy, anterior vitrectomy, and IOL implantation was done in children 8 years or younger, while older children underwent only lens aspiration and IOL implantation.
A total of 178 eyes of 120 children underwent cataract surgery with primary IOL implantation. Mean age at the time of surgery was 6.9 years (range: 3 months to 15 years). Average follow-up time was 13.7 (±5.9) months. Associated ocular anomalies were present in 84 (47.1%) eyes. Postoperative complications were found in 33 eyes (18.13%) with inflammatory membrane being the most common (10.1%). Two eyes (1.1%) developed endophthalmitis. Second intervention was needed in 12 (6.5%) eyes. Preoperative vision of less than 6/60 was present in 105 eyes (57.69%). Final best corrected visual acuity of 6/12 or better was found in 81 (44.5%) eyes.
Our study shows that hydrophilic IOL is suitable for use in children. Results of this study are comparable with other studies on pediatric cataract surgeries using hydrophobic acrylic intraocular lenses. Low cost hydrophilic lens implantation is an effective approach in managing pediatric cataract surgery in developing countries like Nepal.
评估在患有先天性和发育性白内障的儿童中植入亲水性丙烯酸人工晶状体(IOL)的白内障手术效果。
回顾性分析2011年1月至2014年12月在尼泊尔一家三级眼科医院接受亲水性IOL植入白内障手术的先天性或发育性白内障儿童的病历。8岁及以下儿童进行一期后囊切开、前部玻璃体切除术和IOL植入,而年龄较大的儿童仅进行晶状体抽吸和IOL植入。
共有120名儿童的178只眼接受了一期IOL植入白内障手术。手术时的平均年龄为6.9岁(范围:3个月至15岁)。平均随访时间为13.7(±5.9)个月。84只眼(47.1%)存在相关眼部异常。33只眼(18.13%)出现术后并发症,其中炎症膜最常见(10.1%)。2只眼(1.1%)发生眼内炎。12只眼(6.5%)需要二次干预。105只眼(57.69%)术前视力低于6/60。最终最佳矫正视力达到6/12或更好的有81只眼(44.5%)。
我们的研究表明亲水性IOL适用于儿童。本研究结果与其他使用疏水性丙烯酸人工晶状体的小儿白内障手术研究结果相当。低成本的亲水性晶状体植入是尼泊尔等发展中国家治疗小儿白内障手术的有效方法。